The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Cancer Res
; 64(18): 6626-34, 2004 Sep 15.
Article
in En
| MEDLINE
| ID: mdl-15374977
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phthalazines
/
Pyridines
/
Antineoplastic Combined Chemotherapy Protocols
/
Angiogenesis Inhibitors
/
Vascular Endothelial Growth Factor Receptor-2
/
Histone Deacetylase Inhibitors
/
Hydroxamic Acids
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Res
Year:
2004
Document type:
Article